Jul 17, 2019
Preferred provider program pools expertise to deliver highest-quality sequencing data, even for challenging projects
CORALVILLE, IA (July 17, 2019) – As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies. In line with this mission, the company has launched a preferred sequencing provider program with McDonnell Genome Institute (MGI) at Washington University. The program will make challenging NGS problems easier to solve – thanks to the combined expertise of a world-class research institute and a leading genomics solutions provider.
MGI is a renowned research institute with a rich history in genomics and an early adopter of IDT’s new sequencing technologies. Like IDT, MGI advocates for researchers by sharing its expertise with the community via comprehensive genomics services, which include sequencing, bioinformatics, clinical services, and technical development. IDT has developed a close relationship with MGI over a number of years – MGI’s feedback and input has helped to shape the development of several products such as the unique adapters used on Illumina systems, now also available as Custom NGS Adapters.
Trey Martin, President of IDT, commented, “We are delighted to announce MGI and Washington University as an IDT preferred sequencing provider. MGI has been an invaluable resource to us over the years, as we strive to push our NGS sequencing products further. By pooling our expertise, we will make more NGS research projects possible.”
By working together, IDT and MGI provide an exciting service for researchers, pooling MGI’s expertise in sequencing and informatics with IDT’s expertise in producing high quality, reproducible and flexible products at a price accessible to MGI’s customers. The partnership will also open up NGS to researchers who otherwise would not have access to facilities for large-scale genomics projects. By sending pilot projects to MGI, researchers can attain high-quality, reliable sequencing data, which can then be used to help them decide if larger studies are necessary and to support grant applications, helping to secure funding.
According to MGI’s Director of Technology Development, Bob Fulton, “We have worked closely with IDT for many years and are quite adept in using their products. This new collaboration with IDT will enable MGI to provide world-class sequencing services to research teams that may have more limited sequencing sophistication or capacity. By leveraging MGI’s vast experience and expertise, those groups can focus efforts on other priorities.”
The partnership with Washington University is anticipated to be the first in a series of partnerships, as part of a wider IDT preferred sequencing provider program.
For more information about IDT, please visit www.idtdna.com. For more information about MGI, Washington University, please visit https://www.genome.wustl.edu/
Follow IDT on twitter @idtdna for real-time updates and insights.
About IDT
Integrated DNA Technologies, Inc. (IDT) develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP services, IDT manufactures products used in diagnostic tests for many forms of cancer and most inherited and infectious diseases. IDT is widely recognized as the industry leader in custom nucleic acid manufacture, serving over 120,000 life sciences researchers. IDT has its manufacturing headquarters in Coralville, Iowa, USA, with additional manufacturing sites in San Diego, California, USA; Leuven, Belgium; and Singapore.
Contact
Brian Werger
Manager of Brand & Public Relations
Integrated DNA Technologies
idtpr@idtdna.com
About MGI
The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. MGI aims to improve the human condition by producing, studying, and interpreting high-quality genome-based data that drives biological discoveries that range from the bench to the hospital bedside. MGI values the open sharing of information and ideas and encourages collaboration while also engaging the next generation of scientists through educational outreach efforts. As part of the Washington University campus, MGI works with Barnes-Jewish Hospital, Siteman Cancer Center, and Washington University School of Medicine.